Prof Dr. Angus Dalgleish Reveals the Suppressed Science

Prof Dr. Angus Dalgleish Reveals the Suppressed Science Behind T-Cell Immunity & IMM-101

A bombshell revelation from renowned oncologist Dr. Angus Dalgleish: What if the key to defeating viruses like COVID and even preventing cancer already existed—but was ignored?

In a stunning account, Dr. Dalgleish explains how IMM-101, a mycobacterial vaccine, was shown to supercharge T-cell immunity—the body’s real defense against viruses. Unlike antibodies (which fade and chase variants), T-cells target the virus’s core, making them resistant to mutations.

The Evidence:
Personal Trial: Dr. Dalgleish administered IMM-101 to himself during COVID. Despite being unvaccinated, he developed the highest T-cell response his lab had ever recorded—twice as strong as double-vaccinated individuals.

Long-Term Protection: A single course (4 doses in the first year) provided over two years of immunity. He suffered no colds, flu, or severe COVID—until the effect waned.

Cancer Potential: IMM-101 was originally trialed for melanoma. Its mechanism? Boosting innate immunity—the same system that fights infections and tumors.

The Scandal:
When COVID hit, Dr. Dalgleish proposed deploying IMM-101 to frontline workers. The response? Rejected. Authorities were fixated on antibody-based vaccines, dismissing a proven, safe, and broad-spectrum solution.

“They suppressed debate. They ignored evidence. It was a mass psychosis.” —Dr. Dalgleish

The Bigger Picture:
No More “Variant Chasing”: T-cells attack conserved regions of viruses, making them effective against any COVID strain—or even flu.

Cancer Prevention: Widespread use could slash cancer rates by reinforcing immune surveillance.

The question remains: Why was this sidelined?